SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom 
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
PLEASANTON, Calif., April 23, 2018 -- Title21 Health Solutions, “Title21”, a provider of cloud technology of Enterprise Quality Management Systems (EQMS) and innovative Cellular Therapy Software was awarded a ‘Best Places to Work’ honor for the second consecutive year by the San Francisco Business Times and Silicon Valley Business Times.
“This is a testament to our talented high-performing team and our culture of excellence and empathy. Title21 is dedicated to helping cure cancer and other life-threatening diseases. Our entire team is passionate about making a difference to advance immunotherapy and gene therapy to save lives. We are continuously innovating our technology solutions to better serve the therapies that leading biotech and healthcare institutions are advancing,” said Title21 Co-Founder and CEO, Lynn Fischer. “Our mission requires a strong sense of urgency to support these hopeful clinical breakthroughs, and our dedicated team delivers that excellent care. Title21 is a growing company where employees ‘connect their head and their heart’ in a culture where they can be lifelong learners and build a rewarding career that truly makes a difference.”
Title21’s Enterprise Quality Management Cloud is deployed at top U.S. hospitals, and Title21 launched the first end-to-end software for Blood and Marrow Transplants, Cell and Gene Therapy and Regenerative Medicine available in the market. “It is incredibly rewarding to work directly with the best institutions that are leading the development in cancer treatments for patients who need it most,” stated Dan Waurzyniak, Systems Architect.
Over 500 Bay Area companies participated in an independent, third-party survey that asked employees to grade their workplace anonymously on criteria such as culture, team dynamics, benefits, compensation, management practices and career development opportunities. Companies that make this list are known for having a purpose-driven mission as well as providing its employees with great compensation and a comprehensive benefits package. To learn more about making a difference at Title21 Health Solutions, please visit the Title21’s Careers Page: www.title21.com/careers.
About Title21 Health Solutions
Title21 Health Solutions continues to gain national recognition for its innovative technology to help hospitals, biotechnology and regenerative medicine improve quality, efficiency and patient safety. Title21 is hiring; visit www.Title21.com!
Media Contact Haley Roebuck [email protected]
